Chemical trader and distributor SBS Philippines Corp. reported a decrease in consolidated net profit in 2022 to P103.7 million, from P180.4 million in 2021.
![](https://static.wixstatic.com/media/1c4fd3_faa6fc9ca8ea4231ac6629da0a427c41~mv2.png/v1/fill/w_980,h_515,al_c,q_90,usm_0.66_1.00_0.01,enc_auto/1c4fd3_faa6fc9ca8ea4231ac6629da0a427c41~mv2.png)
Photo Insert: Operating profit went up by 89.30% to P292.90 million from P154.80 million due to higher sales volumes and price increases.
This was said to have been due to a one-time gain from the deconsolidation of a subsidiary in 2021. Consequently, the group registered a net finance expense of P87.4 million in 2022, from P124.3 million in 2021.
A P312.0 million gain had been recorded in 2021 for the transaction. Other operating income, meanwhile, fell by P19.9 million or 65.% to P10.7 million, caused by a decrease in various management services.
Operating profit went up by 89.30% to P292.90 million from P154.80 million due to higher sales volumes and price increases.
Consolidated finance costs amounted to P93.20 million, down 30% from P133.1 million, and mainly due to the recognition of a day-one loss after discounting certain receivables of a subsidiary. Sales revenue increased by 45.30% to P1.19 billion from P817.5 million.
Industrial chemical sales rose by 113.30% or P121.20 million while the food ingredients segment increased by 37.40% or P94.50 million. The growth was said to have been driven by an improvement in manufacturing activities and a continued increase in consumer demand.
Revenue from animal feeds increased by 4.70% or P12.10 million as the swine industry gradually recovered from the impact of an African Swine Flu outbreak. The cost of goods sold increased by 36.10% to P724 million from P531.90 million.
Gross profit, lastly, rose by 62.40% to P464.10 million from P285.90 million, consistent with the higher sales volume and complemented by an improvement in gross margin of 4.20 percentage points due to favorable product mix and rising prices.
Comments